Brian Abrahams

Jul 13, 2026

Brian Abrahams rated NMRA as Outperform on Jul 13, 2026, setting a price target of 5. Shares have remained stable near 1.6, leaving the 5 target still in play.

Jul 10, 2026

NRIX received a Outperform rating from Brian Abrahams on Jul 10, 2026, aiming for 33. Price action was muted, as shares hovered around 22.71 despite the bullish outlook.

Jul 07, 2026

Brian Abrahams on Jul 07, 2026 assigned NBIX a Outperform rating, with a price target of 195. The recommendation remains pending validation as shares consolidate around 174.1.

Jul 07, 2026

On Jul 07, 2026, Brian Abrahams initiated coverage on BIIB with a Outperform rating and target of 242. Neutral price movement of 1.62% leaves room for interpretation.

Jul 07, 2026

Brian Abrahams issued a Outperform recommendation for BCRX on Jul 07, 2026, price target set at 14. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Jul 07, 2026

On Jul 07, 2026, ACAD was evaluated by Brian Abrahams, who gave a Outperform rating and target of 36. So far, the Buy call awaits clearer momentum, with shares flat at 25.5.

Jul 07, 2026

Brian Abrahams rated VRTX as Outperform on Jul 07, 2026, setting a price target of 570. The stock has underperformed, dropping 8.04% despite the bullish target of 570.

May 08, 2026

On May 08, 2026, Brian Abrahams published a Outperform outlook on XENE, with a target of 82. Shares gained 19.99%, underscoring the accuracy of the bullish outlook toward 82.

Apr 24, 2026

Brian Abrahams on Apr 24, 2026 assigned DMRA a Outperform rating, with a price target of 40. The recommendation remains pending validation as shares consolidate around 28.

Apr 10, 2026

On Apr 10, 2026, Brian Abrahams reaffirmed EVMN with a Outperform rating, targeting 48. Shares slid 52.57% despite the recommendation, highlighting downside risks.

Apr 06, 2026

PHVS was rated Outperform by Brian Abrahams on Apr 06, 2026, with a price objective of 51. A bullish response from the market helped close the gap of 15.93 to the target.

Jan 23, 2026

On Jan 23, 2026, GHRS was given a Outperform rating by Brian Abrahams, with a target price of 40. The stock rallied 51.52% after the rating, narrowing the gap to the target of 40 and validating the bullish stance.

Jan 23, 2026

DFTX received a Outperform rating from Brian Abrahams on Jan 23, 2026, aiming for 36. Momentum has favored the Buy call, with shares climbing from 43.65 to 43.65, rewarding those who trusted the recommendation.

Nov 21, 2025

Brian Abrahams on Nov 21, 2025 assigned CTNM a Outperform rating, with a price target of 22. The Buy call aligned well with market performance, producing a gain of 33.52%.

Nov 13, 2025

On Nov 13, 2025, Brian Abrahams reaffirmed CRBP with a Outperform rating, targeting 53. Shares slid 18.34% despite the recommendation, highlighting downside risks.

Nov 07, 2025

CDTX was rated Outperform by Brian Abrahams on Nov 07, 2025, with a price objective of 145. A bullish response from the market helped close the gap of -76.38 to the target.

Nov 07, 2025

Brian Abrahams issued a Outperform recommendation for MNMD on Nov 07, 2025, price target set at 20. Investors following the Buy call captured upside momentum, with shares now at 20.69.

Nov 04, 2025

Brian Abrahams rated KPTI as Outperform on Nov 04, 2025, setting a price target of 19. The call has proven timely, with shares rising 77.88% toward the price target of 19.

Feb 03, 2025

On Feb 03, 2025, Brian Abrahams published a Outperform outlook on AXSM, with a target of 143. Shares gained 112.49%, underscoring the accuracy of the bullish outlook toward 143.

Jan 28, 2025

Brian Abrahams on Jan 28, 2025 assigned NAMS a Outperform rating, with a price target of 40. The Buy call aligned well with market performance, producing a gain of 55.15%.